Empowering Innovation: Alara Imaging secures an NIH SBIR – Direct to Phase II grant.

  • September 19, 2023

Alara Imaging, a cutting-edge healthcare technology company, has been at the forefront of this mission with its groundbreaking innovation, the Alara Imaging Gateway. This project seeks to bridge the gap between electronic health records and radiology imaging exams to report on national quality measures, ultimately aiming to reduce cancer risk from computed tomography (CT).

The National Institutes of Health (NIH) plays a pivotal role in supporting innovative healthcare research and projects across the United States. Their Direct to Phase II grants are highly competitive and coveted, making Alara Imaging‘s innovation all the more impressive. This grant, valued at $1,973,174, is a testament to the potential and significance of the Alara Imaging Gateway project.

As the NIH grant stipulates, “Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Number R44CA287536. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.” This acknowledgment underscores the significance of the grant and the responsibility that comes with it.

Our Role in Alara Imaging’s Success

We take immense pride in our role as a strategic partner in helping our clients achieve their goals. For Alara Imaging, we provided comprehensive support throughout the entire grant application process. Our team of experts assisted with writing, editing, and proposal management, ensuring that Alara Imaging‘s vision was presented in the most compelling and persuasive manner to secure this grant.

A Bright Future for Early Cancer Detection

The Alara Imaging Gateway innovation is a game-changer in the healthcare sector. By seamlessly integrating electronic health records with radiology imaging exams, it provides a holistic view of a patient’s medical history and imaging data. This integration will enable healthcare professionals to make more informed decisions, reduce the risk of unnecessary CT scans, and ultimately contribute to the reduction of cancer risk associated with CT procedures. This visionary project aligns perfectly with the NIH’s mission to support research that enhances health and saves lives.

Stay Tuned for Exciting Updates

We are excited to follow Alara Imaging’s progress as they embark on this exciting journey. Keep an eye on Alara Imaging’s website and our social media channels for updates on their project’s development and how it will benefit healthcare.

We are passionate about supporting innovative projects and helping clients like Alara Imaging achieve their dreams. You can see our Track Record database here – www.ebhoward.com/trackrecord

Congratulations once again to Alara Imaging on this remarkable achievement.

Ready To Take the Next Step?

We assist our clients in locating, applying for, and evaluating the outcomes of non-dilutive grant funding. We believe non-dilutive funding is a crucial tool for mitigating investment risks, and we are dedicated to guiding our clients through the entire process—from identifying the most suitable opportunities to submitting and managing grant applications.